Insulet (PODD) Operating Income (2010 - 2026)

Insulet (PODD) has 17 years of Operating Income data on file, last reported at $122.1 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Income rose 37.5% year-over-year to $122.1 million; the trailing twelve-month figure through Mar 2026 stood at $507.2 million (up 48.87% YoY), and the FY2025 full-year result was $473.8 million, up 53.38% from the prior year.
• Operating Income for Q1 2026 stood at $122.1 million, down from $146.3 million in the prior quarter.
• Across five years, Operating Income topped out at $146.3 million in Q4 2025 and bottomed at -$26.7 million in Q2 2022.
• The 5-year median for Operating Income is $56.9 million (2024), against an average of $68.4 million.
• The widest annual swing landed in 2022, when Operating Income plunged 201.52%; it then jumped 1789.66% in 2023.
• A 5-year view of Operating Income shows it stood at $23.5 million in 2022, then jumped by 353.19% to $106.5 million in 2023, then gained by 2.63% to $109.3 million in 2024, then soared by 33.85% to $146.3 million in 2025, then dropped by 16.54% to $122.1 million in 2026.
• The last three Operating Income figures came in at $122.1 million (Q1 2026), $146.3 million (Q4 2025), and $117.7 million (Q3 2025), per Business Quant data.

Peer Comparison